CoChat

Stroma‐directed imatinib therapy impairs the tumor‐promoting effect of bone marrow‐derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer

Open access
Shinagawa, Kei, Kitadai, Yasuhiko, Tanaka, Miwako, Sumida, Tomonori, Onoyama, Mieko, Ohnishi, Mayu, Ohara, Eiji, Higashi, Yukihito, Tanaka, Shinji, Yasui, Wataru, Chayama, Kazuaki · 2013 · International Journal of Cancer
Cited by 79

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Bone marrow‐derived mesenchymal stem cells (MSCs) are reported to contribute to formation of tumor‐promoting stromal cells. We reported recently that, in an orthotopic nude mice model of colon cancer, MSCs traveled to tumor stroma, where they differentiated into carcinoma‐associated fibroblast (CAF)‐like cells. We also found that CAFs express platelet‐derived growth factor receptor (PDGFR) at a high level and that imatinib therapy targeting PDGFR in CAFs inhibits growth and metastasis of human colon cancer. These findings led us to examine whether the tumor‐promoting effect of MSCs is impaired by blockade of PDGFR signaling achieved with imatinib. Orthotopic transplantation and splenic injection of human MSCs along with KM12SM human colon cancer cells, in comparison with transplantation of KM12SM cells alone, resulted in significantly greater promotion of tumor growth and liver metastasis. The KM12SM + MSC xenograft enhanced cell proliferation and angiogenesis and inhibited tumor cell apoptosis. When tumor‐bearing animals were treated with imatinib, there was no significant increase in primary tumor volume or total volume of liver metastases, despite the KM12SM+MSC xenograft, and survival in the mixed‐cell group was prolonged by imatinib treatment. Moreover, the ability of MSCs to migrate to tumor stroma was impaired, and the number of MSCs surviving in the tumor microenvironment was significantly decreased. In in vitro experiments, treatment with imatinib inhibited migration of MSCs. Our data suggest that blockade of PDGF signaling pathways influences the interaction between bone marrow‐derived MSCs and tumor cells in the tumor microenvironment and, hence, inhibits the progressive growth of colon cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.27735

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 35

  1. 10.1038/nature07205 · DOI · Paper page
  2. Kitadai Y, 2009, Cancer‐stromal cell interaction and tumor angiogenesis in gastric cancer, Cancer Microenviron
  3. 10.2353/ajpath.2006.060653 · DOI
  4. 10.1002/ijc.22229 · DOI · Paper page
  5. 10.1016/j.cell.2005.02.034 · DOI · Paper page
  6. 10.1002/ijc.25812 · DOI · Paper page
  7. 10.1038/nrc1877 · DOI · Paper page
  8. 10.1002/jor.1100090504 · DOI · Paper page
  9. 10.1016/j.yexcr.2005.03.018 · DOI · Paper page
  10. Studeny M, 2002, Bone marrow‐derived mesenchymal stem cells as vehicles for interferon‐beta delivery into tumors, Cancer Res, 62, 3603
  11. 10.1158/0008-5472.CAN-04-1874 · DOI · Paper page
  12. 10.1634/stemcells.2006-0257 · DOI · Paper page
  13. 10.1038/sj.cgt.7701097 · DOI
  14. 10.1158/1078-0432.CCR-07-0731 · DOI · Paper page
  15. 10.1158/0008-5472.CAN-07-1406 · DOI · Paper page
  16. 10.1002/jcb.10763 · DOI · Paper page
  17. 10.1158/0008-5472.CAN-08-3562 · DOI · Paper page
  18. 10.1158/0008-5472.CAN-10-0538 · DOI · Paper page
  19. 10.1158/0008-5472.CAN-10-1254 · DOI · Paper page
  20. 10.1016/j.ccr.2011.01.020 · DOI · Paper page
  21. 10.3727/096368909X471134 · DOI
  22. 10.1172/JCI9083 · DOI · Paper page
  23. 10.1016/j.bbrc.2005.04.118 · DOI · Paper page
  24. Morikawa K, 1988, Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice, Cancer Res, 48, 6863
  25. Hwang RF, 2003, Inhibition of platelet‐derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model, Clin Cancer Res, 9, 6534
  26. 10.1073/pnas.90.2.393 · DOI · Paper page
  27. 10.1016/j.lungcan.2004.07.977 · DOI · Paper page
  28. 10.2353/ajpath.2009.081030 · DOI · Paper page
  29. 10.1073/pnas.95.3.1050 · DOI · Paper page
  30. 10.3892/ijo_00000680 · DOI
  31. Pietras K, 2001, Inhibition of platelet‐derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors, Cancer Res, 61, 2929
  32. 10.1053/j.seminoncol.2004.03.036 · DOI
  33. 10.1016/j.bmc.2010.08.026 · DOI
  34. Hibi K, 1991, Coexpression of the stem cell factor and the c‐kit genes in small‐cell lung cancer, Oncogene, 6, 2291
  35. 10.1186/1476-4598-5-46 · DOI

Cited by

See all 79

Metadata

Authors
Shinagawa, K., Kitadai, Y., Tanaka, M., Sumida, T., Onoyama, M., Ohnishi, M., Ohara, E., Higashi, Y., Tanaka, S., Yasui, W., & Chayama, K.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2012-08-06
Volume
132
Issue
4
Pages
813-823
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2104693167
Cited by
79
References
15
FWCI
3.33
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.